BK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
BNY Mellon (BK) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The business fundamentals are solid and Q1 was strong, but the current technical setup is weak and there is no Intellectia buy signal today. With the stock already below recent resistance and momentum softening, I would not call this an immediate buy; I would wait for a cleaner entry rather than chase it here.
BK closed at 130.6, slightly below the previous close, with the regular session down 2.21%. The stock is trading below its pivot at 133.162 and under resistance levels at 135.263 and 136.561, while support sits at 131.061 and 129.763. RSI_6 at 36.534 is neutral-to-weak, and the MACD histogram is -0.867 and expanding lower, which signals negative momentum. Converging moving averages suggest the stock is not in a strong trend, and the short-term setup favors caution over immediate entry.
Analysts broadly raised price targets after the earnings beat, with several firms lifting targets into the $136-$150 range. News flow is positive, with BNY announcing digital asset custody support and a strategic partnership for digital asset infrastructure in the UAE, which adds a credible growth narrative. Trend-finding data also suggests modest upside over the next week to month.
The technical picture is weak right now, with negative MACD momentum and the stock trading below pivot resistance. Insider activity is a concern, as insiders have been selling and the selling amount increased 233.59% over the last month. Hedge funds are neutral with no significant accumulation signal. There is no AI Stock Picker or SwingMax signal today, so there is no proprietary catalyst supporting an urgent buy.
In 2026/Q1, BNY Mellon posted a strong quarter. Revenue increased to $5.372 billion, up 16.05% YoY. Net income rose to $1.562 billion, up 35.94% YoY, and EPS increased to $2.24, up 41.77% YoY. This is a clear growth improvement and shows good operating leverage, likely supported by higher fees and stronger market-related income. The latest quarter season is 2026/Q1.
Analysts have turned more constructive recently. Multiple firms raised price targets after the Q1 earnings beat, including Truist to $148, RBC to $142, Morgan Stanley to $139, Evercore to $136, Keefe Bruyette to $150, Barclays to $149, and JPMorgan to $130.50. The rating mix is mixed but generally positive: several Buy/Overweight/Outperform calls coexist with some Hold/Equal Weight views. Wall Street’s pros see stronger fee income, NII expansion, lower expenses, and benefits from AI/crypto-related trends; the cons side is that some firms still view it as fairly valued or only in line with the sector.
